EBOS Group Limited (ASX: EBO)
Australia
· Delayed Price · Currency is AUD
33.04
-0.14 (-0.42%)
Jan 21, 2025, 4:10 PM AEST
EBOS Group Revenue
In the fiscal year ending June 30, 2024, EBOS Group had annual revenue of 13.19B AUD with 7.78% growth. EBOS Group had revenue of 6.61B in the half year ending June 30, 2024, with 20.49% growth.
Revenue
13.19B
Revenue Growth
+7.78%
P/S Ratio
n/a
Revenue / Employee
2.89M
Employees
4,963
Market Cap
6.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 13.19B | 951.65M | 7.78% |
Jun 30, 2023 | 12.24B | 1.50B | 14.00% |
Jun 30, 2022 | 10.73B | 1.53B | 16.64% |
Jun 30, 2021 | 9.20B | 437.35M | 4.99% |
Jun 30, 2020 | 8.77B | 1.84B | 26.48% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 22.18B |
Pro Medicus | 161.50M |
Cochlear | 2.24B |
Sonic Healthcare | 8.97B |
Telix Pharmaceuticals | 645.68M |
Ramsay Health Care | 16.66B |
Ansell | 2.43B |
Sigma Healthcare | 3.48B |